The January performances of the 37 stocks within the fledgling but burgeoning psychedelic bio-pharmaceutical drug stocks sector.

31 biopharmaceutical companies are now involved in the research and development of psychedelic compounds to treat mental health issues and this article tracks the performance of 15 of them in the new Psychedelic Stocks Index and names the other 16.